๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
This study aims to investigate the efficacy and safety of PET regimen combi...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2017-03-01
Trial ID
NCT03273452
Treatments Being Tested
This is a prospective, single arm, single center study to evaluate the effi...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-05-08
Trial ID
NCT05976997
Treatments Being Tested
This study will evaluate the efficacy, safety and patient reported outcomes...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04516655
Treatments Being Tested
This is a prospective single-arm, multicenter, phase Ib clinical trial of P...
Status
Terminated
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Start Date
2022-02-20
Trial ID
NCT05083208
Treatments Being Tested
This is a multicenter prospective single arm phase II study. The purpose of...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2022-01-01
Trial ID
NCT05179213
Treatments Being Tested
* To assess the impact of UB-421 and chidamide in changing HIV-1 viral rese...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT04985890
Treatments Being Tested
This is an open, multicenter, randomized controlled clinical study aimed to...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02-25
Trial ID
NCT05253066
This study evaluates a personalized treatment strategy for patients with la...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Start Date
2026-05-14
Trial ID
NCT07602322
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470